Indiva Secures Agreement with Medical Cannabis by Shoppers Inc.

Medical Cannabis by Shoppers™ portal to offer Bhang® Chocolate and Wana™ Sour Gummies LONDON, Ontario, Oct. 13, 2020 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce an agreement has been secured with Medical Cannabis by Shoppers Inc., a subsidiary ofContinue reading “Indiva Secures Agreement with Medical Cannabis by Shoppers Inc.”

Curaleaf Expands Product Line Featuring Fast Acting Nanoemulsion Technology with NANO Drops

WAKEFIELD, Mass., Oct. 9, 2020 /CNW/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today unveiled Curaleaf NANO Drops, a new addition to its lineup of products utilizing nanoemulsion technology. The Company, whose Select brand recently reached $1 million in sales in just one month in Florida, has launchedContinue reading “Curaleaf Expands Product Line Featuring Fast Acting Nanoemulsion Technology with NANO Drops”

Khiron Corporate Update: Company Reports Accelerated Increase in Medical Cannabis Prescriptions

Khiron reaches more than 3,500 medical cannabis prescriptions filled Medical cannabis prescriptions increased by over 450% in Q3, compared to Q2 of 2020 Khiron’s clinics exceeded 9,000 monthly patient consultations in September, marking a return to pre-pandemic monthly levels, supported by the launch of telehealth consultations Khiron was declared a National Strategic Project by theContinue reading “Khiron Corporate Update: Company Reports Accelerated Increase in Medical Cannabis Prescriptions”

Tilray Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Caused by Chemotherapy in World First Clinical Trial

NANAIMO, B.C.–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that Australian researchers have published preliminary results finding that one of the company’s GMP-produced products is showing promise reducing nausea and vomiting for cancer patients undergoing chemotherapy in a world’s first clinical trial. “so improving the control of nauseaContinue reading “Tilray Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Caused by Chemotherapy in World First Clinical Trial”

WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020

Non-dilutive financing to fund continued growth including accelerating sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients Company financials will now be filed on September 30, 2020 with management-hosted earnings call on October 1, 2020 at 10 a.m. EST — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensedContinue reading “WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020”

Khiron Declared a National Strategic Project by the Government of Colombia

Status Accelerates Ability to Bring New Products and Services to Market The National Interest Strategic Project certification (“PINES”) was established by the Government of Colombia to prioritize the development of specific projects or companies that are deemed by the Government to be able to significantly increase the national economy Khiron’s PINES certification as a Colombian Pharmaceutical ProducerContinue reading “Khiron Declared a National Strategic Project by the Government of Colombia”

Namaste Technologies in Collaboration with High Tide Announces Entrance into the Direct-to-Consumer Recreational Cannabis Market at CannMart.com using its Proprietary VendorLink Marketplace

Namaste Technologies in Collaboration with High Tide Announces Entrance into the Direct-to-Consumer Recreational Cannabis Market at CannMart.com using its Proprietary VendorLink Marketplace – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) and High Tide Inc. (“High Tide”) (CSE:HITI) (OTCQB:HITIF) (FRA:2LY) today announced that wholly-owned subsidiaries of each corporation recently entered into a CannMart MarketplaceContinue reading “Namaste Technologies in Collaboration with High Tide Announces Entrance into the Direct-to-Consumer Recreational Cannabis Market at CannMart.com using its Proprietary VendorLink Marketplace”

MediPharm Labs Enters Growing Latin American Medical Cannabis Market; Enters Supply Agreement With Cann Farm Peru

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary MediPharm Labs Inc. will supply premium, formulated cannabis oil to Cann Farm Peru S.A.C., a Lima-based producer and distributor serving Peruvian and other markets inContinue reading “MediPharm Labs Enters Growing Latin American Medical Cannabis Market; Enters Supply Agreement With Cann Farm Peru”

MediPharm Labs Australia Expands Revenue Opportunity On Expanded GMP Licence

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its Australian operation – MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”) – has received an important enabling amendment to its Good Manufacturing Practice (“GMP”) Certification and LicenceContinue reading “MediPharm Labs Australia Expands Revenue Opportunity On Expanded GMP Licence”